IL223543A - תכשיר רוקחות המכיל 1–(4–(4–(4,3–דיכלורו–2–פלואורופנילאמינו)–7–מתוקסיקווינאזולינ–6–אילוקסי)פיפרידינ–1–איל)פרופ–2–אן–1–און או מלח מקובל פרמצבטי שלו ותוספת חומצית - Google Patents

תכשיר רוקחות המכיל 1–(4–(4–(4,3–דיכלורו–2–פלואורופנילאמינו)–7–מתוקסיקווינאזולינ–6–אילוקסי)פיפרידינ–1–איל)פרופ–2–אן–1–און או מלח מקובל פרמצבטי שלו ותוספת חומצית

Info

Publication number
IL223543A
IL223543A IL223543A IL22354312A IL223543A IL 223543 A IL223543 A IL 223543A IL 223543 A IL223543 A IL 223543A IL 22354312 A IL22354312 A IL 22354312A IL 223543 A IL223543 A IL 223543A
Authority
IL
Israel
Prior art keywords
methoxyquinazolin
fluorophenylamino
yloxy
piperidin
ene
Prior art date
Application number
IL223543A
Other languages
English (en)
Original Assignee
Hanmi Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Science Co Ltd filed Critical Hanmi Science Co Ltd
Publication of IL223543A publication Critical patent/IL223543A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL223543A 2010-06-11 2012-12-10 תכשיר רוקחות המכיל 1–(4–(4–(4,3–דיכלורו–2–פלואורופנילאמינו)–7–מתוקסיקווינאזולינ–6–אילוקסי)פיפרידינ–1–איל)פרופ–2–אן–1–און או מלח מקובל פרמצבטי שלו ותוספת חומצית IL223543A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100055549A KR101217526B1 (ko) 2010-06-11 2010-06-11 아마이드 유도체 또는 이의 약학적으로 허용 가능한 염을 포함하는 약제학적 조성물
PCT/KR2011/004271 WO2011155793A2 (en) 2010-06-11 2011-06-10 Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof

Publications (1)

Publication Number Publication Date
IL223543A true IL223543A (he) 2017-02-28

Family

ID=45098550

Family Applications (1)

Application Number Title Priority Date Filing Date
IL223543A IL223543A (he) 2010-06-11 2012-12-10 תכשיר רוקחות המכיל 1–(4–(4–(4,3–דיכלורו–2–פלואורופנילאמינו)–7–מתוקסיקווינאזולינ–6–אילוקסי)פיפרידינ–1–איל)פרופ–2–אן–1–און או מלח מקובל פרמצבטי שלו ותוספת חומצית

Country Status (26)

Country Link
US (1) US20130071452A1 (he)
EP (1) EP2580206B1 (he)
JP (1) JP5852105B2 (he)
KR (1) KR101217526B1 (he)
CN (1) CN102933573B (he)
AR (1) AR081870A1 (he)
AU (1) AU2011262662B2 (he)
BR (1) BR112012031510B1 (he)
CA (3) CA3012771C (he)
CL (1) CL2012003487A1 (he)
CO (1) CO6620015A2 (he)
DK (1) DK2580206T3 (he)
ES (1) ES2556457T3 (he)
IL (1) IL223543A (he)
MA (1) MA34368B1 (he)
MX (1) MX2012014440A (he)
MY (1) MY164015A (he)
NZ (1) NZ605601A (he)
PE (1) PE20130236A1 (he)
PH (1) PH12012502445A1 (he)
PL (1) PL2580206T3 (he)
SG (1) SG185661A1 (he)
TW (1) TWI424995B (he)
UA (1) UA109281C2 (he)
WO (1) WO2011155793A2 (he)
ZA (1) ZA201300241B (he)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828391B2 (en) 2011-05-17 2014-09-09 Boehringer Ingelheim International Gmbh Method for EGFR directed combination treatment of non-small cell lung cancer
KR101317809B1 (ko) 2011-06-07 2013-10-16 한미약품 주식회사 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물
KR20140096571A (ko) * 2013-01-28 2014-08-06 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
KR102771603B1 (ko) 2016-11-17 2025-02-24 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 Egfr 또는 her2 엑손 20 돌연변이를 갖는 암 세포에 대한 항종양 활성을 갖는 화합물
TWI808958B (zh) 2017-01-25 2023-07-21 美商特普醫葯公司 涉及二芳基巨環化合物之組合療法
US20180333415A1 (en) * 2017-05-19 2018-11-22 Regents Of The University Of Minnesota Therapeutic methods
KR102227486B1 (ko) * 2017-06-30 2021-03-12 롯데정밀화학 주식회사 프로톤 펌프 저해제를 포함하는 경구용 고형제제 조성물, 이를 포함하는 경구용 고형제제 및 그 제조방법
AU2019243738B2 (en) 2018-03-27 2024-05-30 Board Of Regents, The University Of Texas System Compounds with anti-tumor activity against cancer cells bearing HER2 exon 19 mutations
CA3101657A1 (en) 2018-06-25 2020-01-02 Spectrum Pharmaceuticals, Inc. Combination of poziotinib with cytotoxic agent and/or other molecularly targeted agent and use thereof
BR112021004527A2 (pt) * 2018-09-14 2021-06-08 Spectrum Pharmaceuticals, Inc. kits e métodos para tratamento contra câncer
MX2021011925A (es) * 2019-03-29 2021-11-03 Univ Texas Compuestos con actividad antitumoral contra celulas cancerigenas que portan inserciones del exon 21 del receptor 2 del factor de crecimiento epidermico humano.
EP3962908A4 (en) 2019-04-25 2022-10-26 Board of Regents, The University of Texas System HETEROCYCLIC INHIBITORS OF TYROSINE KINASE
JP7556502B2 (ja) 2019-05-09 2024-09-26 フジフィルム セルラー ダイナミクス，インコーポレイテッド ヘパトサイトの作製方法
BR112022007744A2 (pt) * 2019-10-24 2022-07-19 Hanmi Pharm Ind Co Ltd Preparação farmacêutica compreendendo um derivado de amida inibidor do crescimento de células câncer e produto farmacêutico que a contem
JP7777533B2 (ja) 2020-01-29 2025-11-28 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム Ｎｒｇ１融合体を有するがんの治療のためのポジオチニブの使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR980008219A (ko) * 1996-07-16 1998-04-30 김상응 안정화된 주사제용 약제학적 조성물
GB9718972D0 (en) * 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
CA2384291A1 (en) * 1999-09-21 2001-03-29 Astrazeneca Ab Quinazoline derivatives and their use as pharmaceuticals
CN1882570B (zh) * 2003-09-19 2010-12-08 阿斯利康(瑞典)有限公司 喹唑啉衍生物
WO2005030757A1 (en) * 2003-09-25 2005-04-07 Astrazeneca Ab Quinazoline derivatives
GB0322409D0 (en) * 2003-09-25 2003-10-29 Astrazeneca Ab Quinazoline derivatives
TWI377944B (en) * 2007-06-05 2012-12-01 Hanmi Holdings Co Ltd Novel amide derivative for inhibiting the growth of cancer cells
JP5649157B2 (ja) * 2009-08-01 2015-01-07 住友電気工業株式会社 半導体素子およびその製造方法

Also Published As

Publication number Publication date
MA34368B1 (fr) 2013-07-03
JP5852105B2 (ja) 2016-02-03
CL2012003487A1 (es) 2013-02-22
RU2013100943A (ru) 2014-07-20
CA2801631C (en) 2018-09-04
TWI424995B (zh) 2014-02-01
WO2011155793A2 (en) 2011-12-15
NZ605601A (en) 2014-11-28
AU2011262662A1 (en) 2013-01-31
ZA201300241B (en) 2014-03-26
SG185661A1 (en) 2012-12-28
AR081870A1 (es) 2012-10-24
WO2011155793A3 (en) 2012-04-26
UA109281C2 (uk) 2015-08-10
CA3012771A1 (en) 2011-12-15
CO6620015A2 (es) 2013-02-15
BR112012031510A2 (pt) 2016-11-08
TW201204711A (en) 2012-02-01
PH12012502445A1 (en) 2013-02-11
HK1181389A1 (en) 2013-11-08
EP2580206B1 (en) 2015-09-23
PL2580206T3 (pl) 2016-03-31
CN102933573B (zh) 2014-12-24
CA3012771C (en) 2021-10-12
AU2011262662B2 (en) 2015-06-25
MX2012014440A (es) 2013-02-26
EP2580206A2 (en) 2013-04-17
ES2556457T3 (es) 2016-01-18
PE20130236A1 (es) 2013-03-18
EP2580206A4 (en) 2014-01-22
BR112012031510B1 (pt) 2021-06-22
JP2013531648A (ja) 2013-08-08
KR101217526B1 (ko) 2013-01-02
CA2801631A1 (en) 2011-12-15
US20130071452A1 (en) 2013-03-21
CA3127906A1 (en) 2011-12-15
CN102933573A (zh) 2013-02-13
KR20110135685A (ko) 2011-12-19
MY164015A (en) 2017-11-15
DK2580206T3 (en) 2016-01-11

Similar Documents

Publication Publication Date Title
IL223543A (he) תכשיר רוקחות המכיל 1–(4–(4–(4,3–דיכלורו–2–פלואורופנילאמינו)–7–מתוקסיקווינאזולינ–6–אילוקסי)פיפרידינ–1–איל)פרופ–2–אן–1–און או מלח מקובל פרמצבטי שלו ותוספת חומצית
ZA201300920B (en) Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same
IL224288A (he) נגזרות של פיראזולאמיד מותמר, תכשירי רוקחות המכילים אותן והשימוש בהם
IL214822A0 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
IL220863A (he) נגזרות אוקסאזול מעכבי קינאז, תכשירים רפואיים המכילים אותן ושימושים בהן
IL216132A (he) תרכובות דיאמינו הטרוציקלי קרבוקסאמיד, שימושיהן ותכשירי רוקחות ומעכבים המכילים אותן
IL224976A (he) תולדות מותמרות של 1h–אינדאזול ותכשיר רוקחות המכיל אותן
IL220571A (he) תרכובות של 3–(3–פניל–אימידאזו[5,4–b]פירידיניל)–2–אמינופירידין המותמרות ותכשירים רוקחיים המכילים אותן
IL214175A (he) נגזרות של אמינוטטרלין, הרכבים רוקחיים המכילים אותן ושימושן
IL214425A (he) תרכובות הטרוציקליות ביציקליות מותמרות, תכשירים רוקחיים המכילים אותן ושימושים שלהן
ZA201200367B (en) Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
IL232914A0 (he) תולדות אזטידין חדשות, תכשירי רוקחות ושימושים שלהן
IL216113A (he) נגזרות מותמרות של אינדאזול ואזא–אינדאזול , תכשירים רוקחים המכילים אותן ושימושים בהן
IL236057B (he) תולדות 4,2,1–טריאזין–6–קרבוקסאמיד ותכשירי רוקחות המכילים אותן
IL221742A (he) תכשיר רוקחי אוראלי המכיל דביגטרן אטקסילט
IL228408A0 (he) תולדות כפאלוספורין ותכשירים רפואיים שלהן
IL217927A (he) תרכובות אזאהטרוציקליות ותכשירי רוקחות וסט המכילים אותן
IL222707B (he) תרכובות סטרואידיות של 16–כלורו– ו– 16, 16–דיכלורו–( 4–אלפא, 4–ביטא)–17–ביטא–(2–אוקסו–2h–פיראנ–5–יל) ותכשירים רוקחיים המכילים אותן
IL220586A (he) תרכובת קרבוקסאמיד, הרכב רוקחי המכיל אותה ושימוש בה
PL2320739T3 (pl) Kompozycje farmaceutyczne i sposoby ich stabilizowania
IL231699A0 (he) תולדות בנזיל פיפרידין, ותכשירי רוקחות המכילים אותן
SI2536412T1 (sl) Inhalabilen farmacevtski sestavek
ZA201104670B (en) Pharmaceutical composition comprising aleglitazar
ZA201307216B (en) Novel oxazolidinone derivative and pharmaceutical composition including the same
SI2220047T1 (sl) Derivati kinolina, farmacevtski sestavki, ki jih vsebujejo in njihova uporaba

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed